On Thursday, December 9, 2021, the Centers for Disease Control and Prevention recommended everyone 16 years and older receive a booster shot. At this time, only the Pfizer-BioNTech COVID-19 vaccine is authorized and recommended for those aged 16 and 17 years.
On Friday, November 19, 2021, the U.S. Food and Drug Administration amended the emergency use authorizations (EUA) for both the Moderna and Pfizer-BioNTech COVID-19 vaccines authorizing use of a single booster dose for all individuals 18 years of age and older after completion of primary vaccination with any FDA-authorized or approved COVID-19 vaccine.
For Moderna and Pfizer-BioNTech COVID-19 vaccines, a single COVID-19 vaccine booster dose is recommended 5 months after completion of an mRNA primary series. The Moderna booster dose is a smaller 50 microgram dose.
For Janssen (Johnson & Johnson) COVID-19 vaccine, a single COVID-19 vaccine booster dose is recommended for people aged 18 years and older, 2 months after receipt of the initial Johnson & Johnson dose, under the FDA’s Emergency Use Authorization.